GL1X · GenesisL1 explorer

Research workbench

AlphaFold monomer V2.0 prediction for trans-aconitate 2-methyltransferase (B2K7X9)

Analyse AlphaFold monomer V2.0 prediction for trans-aconitate 2-methyltransferase… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

Accession
B2K7X9
Type
protein
Length
258 residues
Chains
1
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0x1ED4a68B4011314730adE976b56Ad4cA21b54dcD
Molecule
Trans-aconitate 2-methyltransferase
UniProt
B2K7X9
Pockets
3 · best druggability 0.73

Structure

1 distinct chain · 41% helix, 24% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATrans-aconitate 2-methyltransferaseprotein25841% helix, 24% strandB2K7X9

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13620.730.8448empty
2740.380.7814empty
3700.360.7717empty

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.